A fixed-dose combination of ledipasvir and sofosbuvir ± ribavirin for treatment of hepatitis C infection: a systematic review and meta-analysis

Background Novel antivirals have shown promising results in the treatment of hepatitis C. Our objective was to perform a meta-analysis of the efficacy and safety of a fixed-dose combination (FDC) of ledipasvir + sofosbuvir and compare outcomes with the addition of ribavirin (RBV) to treatment with t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs & therapy perspectives : for rational drug selection and use 2017-07, Vol.33 (7), p.348-360
Hauptverfasser:	Kunwar, Sumit, Devkota, Ashok Raj, Ghimire, Dipesh K. C., Adhikari, Prabhat
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral drugs Cytokines Drug dosages Evidence-based medicine Genotype & phenotype Hepatitis Hepatitis C Hepatology Infections Interferon Liver cirrhosis Liver diseases Medicine Meta-analysis Mortality Patients Pharmacotherapy Pharmacy Review Article Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!